Sildenafil in the treatment of pulmonary hypertension

The paper describes the clinical use of a phosphodiesterase 5 inhibitor (sildenafll) in a patient with primary pulmonary hypertension during a long-term controlled follow-up. The 6-year use of sildenafll as monotherapy for pulmonary hypertension had a significant positive effect as a decrease in the...

Full description

Bibliographic Details
Main Authors: O. S. Groznova, I. V. Leontyeva, O. V. Todorova
Format: Article
Language:Russian
Published: Ltd. “The National Academy of Pediatric Science and Innovation” 2016-03-01
Series:Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:
Online Access:https://www.ped-perinatology.ru/jour/article/view/286
_version_ 1797875268710301696
author O. S. Groznova
I. V. Leontyeva
O. V. Todorova
author_facet O. S. Groznova
I. V. Leontyeva
O. V. Todorova
author_sort O. S. Groznova
collection DOAJ
description The paper describes the clinical use of a phosphodiesterase 5 inhibitor (sildenafll) in a patient with primary pulmonary hypertension during a long-term controlled follow-up. The 6-year use of sildenafll as monotherapy for pulmonary hypertension had a significant positive effect as a decrease in the functional class of pulmonary hypertension from 3 to 1, an increase in exercise tolerance, improvements in echocardiographic parameters and biochemical markers (brain natriuretic peptide), and a rise in oxygen uptake during cardiorespiratory testing.
first_indexed 2024-04-10T01:45:00Z
format Article
id doaj.art-d60d60c242d240c499dd0ffeb523afe8
institution Directory Open Access Journal
issn 1027-4065
2500-2228
language Russian
last_indexed 2024-04-10T01:45:00Z
publishDate 2016-03-01
publisher Ltd. “The National Academy of Pediatric Science and Innovation”
record_format Article
series Rossijskij Vestnik Perinatologii i Pediatrii
spelling doaj.art-d60d60c242d240c499dd0ffeb523afe82023-03-13T09:12:42ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282016-03-01596939710.21508/1027-4065-2014-59-6-103-110279Sildenafil in the treatment of pulmonary hypertensionO. S. Groznova0I. V. Leontyeva1O. V. Todorova2Научно-исследовательский клинический институт педиатрии, МоскваНаучно-исследовательский клинический институт педиатрии, МоскваНаучно-исследовательский клинический институт педиатрии, МоскваThe paper describes the clinical use of a phosphodiesterase 5 inhibitor (sildenafll) in a patient with primary pulmonary hypertension during a long-term controlled follow-up. The 6-year use of sildenafll as monotherapy for pulmonary hypertension had a significant positive effect as a decrease in the functional class of pulmonary hypertension from 3 to 1, an increase in exercise tolerance, improvements in echocardiographic parameters and biochemical markers (brain natriuretic peptide), and a rise in oxygen uptake during cardiorespiratory testing.https://www.ped-perinatology.ru/jour/article/view/286детилегочная артериальная гипертензияраспространенностьклассификацияклиническая картиналечениеингибитор фосфодиэстеразы-5силденафилкардиореспираторный тест.
spellingShingle O. S. Groznova
I. V. Leontyeva
O. V. Todorova
Sildenafil in the treatment of pulmonary hypertension
Rossijskij Vestnik Perinatologii i Pediatrii
дети
легочная артериальная гипертензия
распространенность
классификация
клиническая картина
лечение
ингибитор фосфодиэстеразы-5
силденафил
кардиореспираторный тест.
title Sildenafil in the treatment of pulmonary hypertension
title_full Sildenafil in the treatment of pulmonary hypertension
title_fullStr Sildenafil in the treatment of pulmonary hypertension
title_full_unstemmed Sildenafil in the treatment of pulmonary hypertension
title_short Sildenafil in the treatment of pulmonary hypertension
title_sort sildenafil in the treatment of pulmonary hypertension
topic дети
легочная артериальная гипертензия
распространенность
классификация
клиническая картина
лечение
ингибитор фосфодиэстеразы-5
силденафил
кардиореспираторный тест.
url https://www.ped-perinatology.ru/jour/article/view/286
work_keys_str_mv AT osgroznova sildenafilinthetreatmentofpulmonaryhypertension
AT ivleontyeva sildenafilinthetreatmentofpulmonaryhypertension
AT ovtodorova sildenafilinthetreatmentofpulmonaryhypertension